NS

Naziya Sultana

Active Director Director DIN 08835027
DIN 08835027 First appointment Aug 2020 Primary industry Chemicals and Materials
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Naziya Sultana

Data last updated:

Naziya Sultana is a Director at Pharmanoble Chem Limited (since 2020). The company operates in Chemicals and Materials.

DIN 08835027
Primary Designation Director
Industry Chemicals and Materials
First Appointment 14 Aug 2020
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Pharmanoble Chem Limited U24233TG2020PLC142836
Director14 Aug 20202020Active

Board colleagues of Naziya Sultana

Directorship timeline

Open interactive timeline →
Pharmanoble Chem Limited
Premium access

Shareholding and investment profile for Naziya Sultana

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Naziya Sultana

Naziya Sultana currently holds 1 directorship: Pharmanoble Chem Limited (Director, since 14 Aug 2020).

Naziya Sultana was first appointed on 14 Aug 2020 as Director at Pharmanoble Chem Limited.

The current boards of Naziya Sultana's companies include Akbar Mohammad (Pharmanoble Chem Limited), Mohammed Abrar (Pharmanoble Chem Limited), Mohammed Akhter (Pharmanoble Chem Limited), Mohammed Akram (Pharmanoble Chem Limited), Rauf Qadri Syed (Pharmanoble Chem Limited), Sumaira Sultana (Pharmanoble Chem Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available